| Information | |
|---|---|
| Name of lifestyle | Metformin |
| Third Class | Antidiabetic |
| Second Class | Drug |
| First Class | Clinical characteristics |
| Unit | NA |
| Stratification |
28084175:NA 26353947:NA |
| Type of influence factor |
Protective factor No statistical significance factor |
| Classification of Lifestyles |
Clinical characteristics |
| The affected types of PCa |
Total PCa Low grade PCa High grade PCa |
| Number of studies involved | 2 |
| 2 Items, 1 Pages <<Prev 1 Next>> All | |||||||
|---|---|---|---|---|---|---|---|
| Research involved | |||||||
| PMID | First auther | Year | Area | Duration | Study type | Sample size | More |
| 28084175 | Antti Haringa | 2016 | Finland | 1996, 1999 | Study cohort | 78615 | baseline outcome |
| 26353947 | Tom Feng | 2015 | randomized , double-blind , placebo-controlled | 540 | baseline outcome | ||